{"nct_id":"NCT04456673","title":"Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2020-07-06","start_date_type":"ACTUAL","primary_completion_date":"2024-02-28","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}